English
Segment disclosures
Company overviewHealth-Right Discoveries, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
10 dimension combinations 79 retained observations 12 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Ancillary Program
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cik0001537663:AncillaryProgramMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 1444060 | USD | 20180511 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 1599652 | USD | 20180417 | Open filing evidence |
Prescription Medicine
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cik0001537663:PrescriptionMedicineMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 480772 | USD | 20180511 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 452700 | USD | 20180417 | Open filing evidence |
Ancillary Program
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hrdv:AncillaryProgramMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 250946 | USD | 20201118 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 844644 | USD | 20201118 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 288010 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 593698 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 305688 | USD | 20200513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 2792808 | USD | 20200330 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 658970 | USD | 20201118 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 2204414 | USD | 20201118 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 722558 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 1545444 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 822886 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 4930352 | USD | 20200330 | Open filing evidence |
Ancillary Program · Billing Services
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hrdv:AncillaryProgramMember;srt:ProductOrServiceAxis=hrdv:BillingServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 4930352 | USD | 20190412 | Open filing evidence |
Ancillary Program · Consulting Services
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hrdv:AncillaryProgramMember;srt:ProductOrServiceAxis=hrdv:ConsultingServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 250946 | USD | 20201118 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 844644 | USD | 20201118 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 288010 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 593698 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 305688 | USD | 20200513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 2792808 | USD | 20200330 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 658970 | USD | 20201118 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 2204414 | USD | 20201118 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 722558 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 1545444 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 822886 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 4930352 | USD | 20200330 | Open filing evidence |
Billing Services
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hrdv:BillingServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 250405 | USD | 20201118 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 844644 | USD | 20201118 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 288010 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 593698 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 305688 | USD | 20200513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 2792808 | USD | 20200330 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 658970 | USD | 20201118 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 2204414 | USD | 20201118 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 722558 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 1545444 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 822886 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 4930352 | USD | 20200330 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 1083773 | USD | 20191113 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 4027735 | USD | 20191113 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 1499903 | USD | 20190809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 2943962 | USD | 20190809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 1444060 | USD | 20190516 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 1599652 | USD | 20190412 | Open filing evidence |
OTC And Prescription Medication
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hrdv:OTCAndPrescriptionMedicationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 93087 | USD | 20201118 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 254569 | USD | 20201118 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 85436 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 162023 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 76587 | USD | 20200513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 674853 | USD | 20200330 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 169332 | USD | 20201118 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 585148 | USD | 20201118 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 194693 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 415816 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 221123 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 1353571 | USD | 20200330 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 278183 | USD | 20191113 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 1151555 | USD | 20191113 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 392792 | USD | 20190809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 873372 | USD | 20190809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 480772 | USD | 20190516 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 452700 | USD | 20190412 | Open filing evidence |
OTC And Prescription Medication · Product
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hrdv:OTCAndPrescriptionMedicationMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 92546 | USD | 20201118 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 254569 | USD | 20201118 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 85436 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 162023 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 76587 | USD | 20200513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 674853 | USD | 20200330 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 169332 | USD | 20201118 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 585148 | USD | 20201118 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 194693 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 415816 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 221123 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 6283923 | USD | 20200330 | Open filing evidence |
Prescription Medicine
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hrdv:PrescriptionMedicineMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 1353571 | USD | 20190412 | Open filing evidence |
Prescription Medicine · Product
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hrdv:PrescriptionMedicineMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 1353571 | USD | 20190412 | Open filing evidence |